October 26, 2026 · Gastroenterology · DOI: 10.1053/j.gastro.2026.10.376

TASTY AND HEALTHY DIET REDUCES FECAL CALPROTECTIN IN HIGH-RISK FIRST-DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE: PIONIR RANDOMIZED CROSSOVER TRIAL.

Listen to this summary

The PIONIR randomized crossover trial asked whether the Tasty&Healthy (T&H) diet can reduce fecal calprotectin, a marker of intestinal inflammation, in healthy first-degree relatives of Crohn's disease patients who have persistently elevated calprotectin but no diagnostic evidence of disease. In this 29-participant study, fecal calprotectin was lower after 8 weeks on T&H than on habitual diet (median 64 vs. 112 μg/g; P=.022), and a ≥50% reduction was far more common with T&H (71% vs. 27%). The authors conclude that low-grade intestinal inflammation in this high-risk group is modifiable through diet, supporting larger long-term dietary prevention trials.

Dan Turner, Sarah Kenigsberg, Luba Plotkin, Yonat Aharoni-Frutkoff, Menachem Sokolik, Gili Focht, Sara Gasasa, Williams Turpin, Alyssa M Waslyk, Oren Ledder, Anne M Griffiths, Inez Martincevic, Hien Q Huynh, Lihi Godny, Irit Avni-Biron, Joana Torres, Remo Panaccione, Kevan Jacobson, Anthony Otley, Tali Sharar-Fischler, Qilong Li, Asaf Azulay, Rotem Sigall-Boneh, Sun-Ho Lee, Ken Croitoru

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play